BDSX stock forecast
Our latest prediction for Biodesix Inc's stock price was made on the Feb. 3, 2023 when the stock price was at 1.93$.
In the short term (2weeks), BDSX's stock price should underperform the market by -3.56%. During that period the price should oscillate between -15.32% and +10.77%.
In the medium term (3months), BDSX's stock price should underperform the market by -14.92%. During that period the price should oscillate between -31.56% and +23.73%.
Get email alertsCreate a solid portfolio with BDSX
About Biodesix Inc
Biodesix, Inc. operates as a biotechnology company. The Company offers non-small cell lung cancer pretreatment serum tests and laboratory testing. Biodesix provides diagnostic tools and equipment for blood and tissue analysis in the United States.
At the moment the company generates 35M USD in revenues.
On its last earning announcement, the company reported a loss of None$ per share.
The book value per share is -0.80$
Three months stock forecastFeb. 3, 2023
Financials
| Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 35M | 100.00% | -48M | -135.01% | -38M | - | - | - | 41M | -0.80 | - | - | - |